Latest N-methyl-D-aspartic acid Stories
The N-methyl-D-aspartic acid (NMDA) receptor dysfunction in the brain of aged animals has been shown.
For several years, the pharmaceutical industry has tried to develop drugs that target a specific neurotransmitter receptor in the brain, the NMDA receptor.
New genetic factors predisposing to schizophrenia have been uncovered in five families with several affected relatives.
Since the 1960s, psychiatrists have been hunting for substances made by the body that might accumulate in abnormally high levels to produce the symptoms associated with schizophrenia.
Structural biologists at Cold Spring Harbor Laboratory (CSHL) in collaboration with colleagues at Emory University have determined the molecular structure of a key portion, or subunit, of a receptor type commonly expressed in brain cells.
MIAMI and EVANSTON, Ill., Dec.
SAN DIEGO and EVANSTON, Ill., Nov.
A new class of compounds identified by researchers at Emory University School of Medicine could be developed into drugs for the treatment of schizophrenia.
New neuroscience research by life scientists from UCLA and Australia may potentially help people who have lost their ability to remember due to brain injury or disease.
EVANSTON, Ill., Aug.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.